Bavarian Nordic may well upgrade again, says Sydbank analyst

The US government’s order of Bavarian Nordic’s monkeypox vaccine will not be the last, says Sydbank senior analyst Søren Løntoft Hansen.
Photo: Christinne Muschi/REUTERS / X01320
Photo: Christinne Muschi/REUTERS / X01320
by marketwire, translated by catherine brett

On Friday, June 10, Bavarian Nordic upgraded its financial guidance for 2022 for the third time in three weeks.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading